Will a merger help these two falling knives turn things around?

Will these two companies be able to stop the rot by merging?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

John Menzies (LSE: MNZS) and DX (LSE: DX) have both had their fair share of problems over the past year, but it now looks as if the two groups have finally stumbled on a solution to their problems by seeking to work together.

Specifically, managements announced this morning that the two firms are in talks regarding the possible sale of John Menzies’ distribution division. DX is proposing to buy the division off Menzies for £60m in cash and the issue of new shares representing 80% of its issued share capital after the deal closes. The cash consideration of the deal will be financed by new borrowings of the enlarged group.

A good deal? 

The deal looks on paper to be a sensible decision. Based on a preliminary joint assessment, the boards estimate that the combination would generate cost synergies in the range of £8m to £12m per annum — a sizeable figure compared to the acquisition price.

However, after the deal closes, it seems John Menzies’ shareholders will end up owning DX, which may not be a favourable outcome considering the company’s past mistakes. 

Under the terms of the deal, it is intended that the balance of the new DX shares issued to fund the merger will be issued to Menzies’ shareholders pro rata their holdings at the relevant date. On this basis, current DX shareholders would own in aggregate 20% of DX’s issued share capital with 75% of the company owned by Menzies’ investors. The remaining 5% of the group will be given to Menzies’ defined benefit pension scheme to meet pension obligations.

Still, on the face of it, this deal seems to make a lot of sense for DX’s investors. By combining with the distribution division, DX should be able to cut costs significantly and improve profit margins to turn around its operating performance. The company has been blighted by operational problems during the past year, and losses have ballooned.

Plenty of problems

Alongside today’s merger proposal, DX also announced its interim results for the six months ended 31 December 2016 this morning, revealing a loss before tax of £29.3m and an adjusted profit before tax of £0.6m, down from £2.4m for the same period a year ago. The company continues to restructure to improve returns and drive revenues, and it seems that the Menzies deal is part of this. But whether or not it will turn out to be a sensible acquisition in the long term is not clear. 

Considering the operational issues DX has reported over the past year, I’m sceptical of whether or not management can successfully integrate Menzies’ distribution business without any further problems. That being said, with the deal structured as it is, if DX  can’t manage with the larger operation then Menzies could easily swoop and acquire the rest of the business it does not already own. All in all, the  deal looks to make sense on paper but it remains to be seen whether or not DX’s management can successfully pull off a merger of this size.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian man making doubtful face at camera
Investing Articles

Surprise! This monopoly stock has taken over my Stocks and Shares ISA (again)

Our writer has a (nice) dilemma in his Stocks and Shares ISA portfolio after one incredible growth stock rocketed higher…

Read more »

Investing Articles

10.5% yield – but could the abrdn share price get even cheaper?

Christopher Ruane sees some things to like about the current abrdn share price. But will that be enough to overcome…

Read more »

Investing Articles

£9,000 to invest? These 3 high-yield shares could deliver a £657 annual passive income

The high yields on these dividend shares sail sit well above the FTSE 100 average of 3.6%. Here's why I…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

I’ve got £2k and I’m on the hunt for cheap shares to buy in December

Harvey Jones finally has some cash in his trading account and is hunting for cheap shares to buy next month.…

Read more »

Investing Articles

Down 25% with a 4.32% yield and P/E of 8.6! Is this my best second income stock or worst?

Harvey Jones bought GSK shares hoping to bag a solid second income stream while nailing down steady share price growth…

Read more »

Investing Articles

Here’s how the Legal & General dividend yield could ultimately hit 15%!

The Legal & General dividend yield is already among the best of any FTSE 100 share. Christopher Ruane explores some…

Read more »

Investing Articles

Is December a good time for me to buy UK shares?

This writer is weighing up which shares to buy for his portfolio next month, and one household name from the…

Read more »

Investing Articles

Is it time to dump my Lloyds shares and never look back?

Harvey Jones was chuffed with his Lloyds shares but recent events have made him rethink his entire decision to go…

Read more »